STC1 is a Novel Biomarker Associated with Immune Characteristics and Prognosis of Bladder Cancer

BACKGROUND: Stanniocalcin-1 (STC1) is a well-studied oncogene that promotes different types of cancer progression. However, the expression status of STC1, the values of STC1 on prognosis, and its immune characteristic in bladder cancer (BLCA) have not been well examined. METHODS: The expression of S...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jiale, Wei, Xuedong, You, Jiawei, Yue, Wenchang, Ouyang, Jun, Ling, Zhixin, Hou, Jianquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445105/
https://www.ncbi.nlm.nih.gov/pubmed/34539184
http://dx.doi.org/10.2147/IJGM.S329723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445105/
https://www.ncbi.nlm.nih.gov/pubmed/34539184
http://dx.doi.org/10.2147/IJGM.S329723

Ejemplares similares